Publication

Subgenomic RNA Abundance Relative to Total Viral RNA Among Severe Acute Respiratory Syndrome Coronavirus 2 Variants

Downloadable Content

Persistent URL
Last modified
  • 06/25/2025
Type of Material
Authors
    Maxwell Su, Emory UniversitySara Ping, Emory UniversityPhuong-Vi Nguyen, Emory UniversityAlejandra Rojas, Instituto de Investigaciones en Ciencias de la Salud Universidad Nacional de AsuncionLaila Hussaini, Emory UniversityLudy Registre Carmola, Emory UniversityAzmain Taz, Emory UniversityJulie Sullivan, The Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesGregory Martin, Emory UniversityAnne Piantadosi, Emory UniversityMagaly Martinez, Instituto de Investigaciones en Ciencias de la Salud Universidad Nacional de AsuncionWilbur Lam, Emory UniversityEvan Anderson, Emory UniversityJesse Waggoner, Emory University
Language
  • English
Date
  • 2022-11-01
Publisher
  • Oxford University Press
Publication Version
Copyright Statement
  • © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 9
Issue
  • 11
Start Page
  • ofac619
End Page
  • ofac619
Grant/Funding Information
  • This work was supported by funding from the Consejo Nacional de Ciencia y Tecnología (CONACYT) with support from el Fondo para la Excelencia de la Educacción y la Investigación (FEEI), Paraguay, PINV20-239 (to M. M.); the National Institutes of Health (grant numbers U54 EB027690 02S1, U54 EB027690 03S1, U54EB027690 03S2, and UL1TR002378); and the Doris Duke Charitable Foundation (Clinical Scientist Development Award 2019089 to J. J. W.). The ROAPS study is supported by a contract from Pfizer, Inc.
Supplemental Material (URL)
Abstract
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) subgenomic RNA (sgRNA) may indicate actively replicating virus, but sgRNA abundance has not been systematically compared between SARS-CoV-2 variants. sgRNA was quantified in 169 clinical samples by real-time reverse-transcription polymerase chain reaction, demonstrating similar relative abundance among known variants. Thus, sgRNA detection can identify individuals with active viral replication regardless of variant.
Author Notes
  • Jesse J. Waggoner, MD, 1760 Haygood Drive NE, Room E-169, Bay E-1, Atlanta, GA 30322; jjwaggo@emory.edu
Keywords
Research Categories
  • Biology, Genetics

Tools

Relations

In Collection:

Items